Almagate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Almagate
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
Formula Al2Mg6(OH)14(CO3)2 · 4 H2O
Molar mass 314.99 g/mol
3D model (Jmol)
  (verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]

Adverse effects[edit]

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]

References[edit]

  1. ^ Moragues, J. B. (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1346–1349. ISSN 0004-4172. PMID 6548918. 
  2. ^ Beneyto, J. F. B. (1984). "Evaluation of a new antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1350–1354. ISSN 0004-4172. PMID 6439224. 
  3. ^ Suau, A. D.; Dominguez Martin, A; Ferrando Cucarella, J; Juncosa Iglesias, L; Muñoz Benitez, J; Nieto Calvet, M; Pérez Gieb, J; Pérez Mota, A; Pineda Garcia, A; Rodriguez Sanchez, E (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (Free full text). Arzneimittel-Forschung. 34 (10A): 1380–1383. ISSN 0004-4172. PMID 6548926.